| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.15 | 0.0007 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.006 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.007 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.29 | 0.01 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.079 | 0.01 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |